|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.17 CNY | -0.70% |
|
+2.11% | -3.44% |
| May. 10 | Fosun Pharma Unit Gets China Marketing Approval for Schizophrenia Tablets | MT |
| May. 09 | Shanghai Fosun Pharmaceutical Unit Secures China Nod to Sell Schizophrenia Drug | MT |
Listed Company Information
An announcement has just been published by the Company in the Chinese section of this website, a corresponding version of which has not been published in this section.
Attachments
Disclaimer
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. published this content on 11 March 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 March 2020 16:59:08 UTC
| 1st Jan change | Capi. | |
|---|---|---|
| -3.44% | 8.04B | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. 
